<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2021.640334</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>High-Resolution Analysis Identifies High Frequency of <italic>KIR-A</italic> Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tao</surname>
<given-names>Sudan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1161610"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Yanmin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1312321/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kichula</surname>
<given-names>Katherine M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jielin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Ji</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Norman</surname>
<given-names>Paul J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/38636"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhu</surname>
<given-names>Faming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1312336/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Blood Center of Zhejiang Province, Key Laboratory of Blood Safety Research of Zhejiang Province</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Division of Biomedical Informatics and Personalized Medicine, and Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus</institution>, <addr-line>Aurora, CO</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Eleanor Riley, University of Edinburgh, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Kouyuki Hirayasu, Kanazawa University, Japan; Roberto Biassoni, Giannina Gaslini Institute (IRCCS), Italy</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Faming Zhu, <email xlink:href="mailto:zfm00@hotmail.com">zfm00@hotmail.com</email>; Paul J. Norman, <email xlink:href="mailto:paul.norman@cuanschutz.edu">paul.norman@cuanschutz.edu</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>04</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>640334</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>12</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>04</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Tao, He, Kichula, Wang, He, Norman and Zhu</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Tao, He, Kichula, Wang, He, Norman and Zhu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Killer cell immunoglobulin-like receptors (KIR) interact with human leukocyte antigen (HLA) class I molecules, modulating critical NK cell functions in the maintenance of human health. Characterizing the distribution and characteristics of KIR and HLA allotype diversity across defined human populations is thus essential for understanding the multiple associations with disease, and for directing therapies. In this study of 176 Zhejiang Han individuals from Southeastern China, we describe diversity of the highly polymorphic <italic>KIR</italic> and <italic>HLA class I</italic> genes at high resolution. <italic>KIR-A</italic> haplotypes, which carry four inhibitory receptors specific for HLA-A, B or C, are known to associate with protection from infection and some cancers. We show the Chinese Southern Han from Zhejiang are characterized by a high frequency of <italic>KIR-A</italic> haplotypes and a high frequency of C1 KIR ligands. Accordingly, interactions of inhibitory KIR2DL3 with C1<sup>+</sup>HLA are more frequent in Zhejiang Han than populations outside East Asia. Zhejiang Han exhibit greater diversity of inhibitory than activating KIR, with three-domain inhibitory KIR exhibiting the greatest degree of polymorphism. As distinguished by gene copy number and allele content, 54 centromeric and 37 telomeric haplotypes were observed. We observed 6% of the population to have <italic>KIR</italic> haplotypes containing large-scale duplications or deletions that include complete genes. A unique truncated haplotype containing only <italic>KIR2DL4</italic> in the telomeric region was also identified. An additional feature is the high frequency of <italic>HLA-B*46:01</italic>, which may have arisen due to selection pressure from infectious disease. This study will provide further insight into the role of <italic>KIR</italic> and <italic>HLA</italic> polymorphism in disease susceptibility of Zhejiang Chinese.</p>
</abstract>
<kwd-group>
<kwd>KIR</kwd>
<kwd>HLA</kwd>
<kwd>KIR/HLA interaction</kwd>
<kwd>Zhejiang Han population</kwd>
<kwd>NK cells</kwd>
</kwd-group>
<contract-num rid="cn001">LY18H080002, 2018RC003, 2019RC031</contract-num>
<contract-num rid="cn002">R56 AI151549, R01 AI128775</contract-num>
<contract-sponsor id="cn001">Science Research Foundation of Zhejiang Province<named-content content-type="fundref-id">10.13039/501100017600</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content>
</contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="95"/>
<page-count count="13"/>
<word-count count="5908"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Natural killer (NK) cells are innate immune effectors having multiple important roles in human health. NK cells are critical in controlling the outcome of infections, tumors and fetal implantation, as well as organ transplantation and immunotherapies (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>). In these roles, NK cell functions are modulated by interactions of their cell surface receptors with ligands expressed by tissue cells (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). In humans, the interactions include polymorphic combinations of killer cell immunoglobulin-like receptors (KIR) with human leukocyte antigen (HLA) class I ligands (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). The extreme genetic variation of KIR and HLA class I directly impacts NK cell functions, and associates with multiple immune-mediated diseases (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Also directly affected by combinatorial diversity, and influencing effector functions in health and disease, maturation of NK cells is guided through appropriate interactions of KIR with HLA class I (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>The <italic>KIR</italic> locus of chromosome 19 (19q13.4) comprises up to 13 genes encoding receptors having distinct ligand specificities and inhibitory or activating functions (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Encoded by each <italic>KIR</italic> haplotype are from one to four inhibitory receptors and up to five activating receptors specific for HLA-A, B or C. Four framework genes, present in most individuals, form the basic structure of the locus. Their arrangement divides the <italic>KIR</italic> locus into centromeric (<italic>KIR3DL3</italic> to <italic>KIR3DP1</italic>) and telomeric (<italic>KIR2DL4</italic> to <italic>KIR3DL2</italic>) oriented regions. Structural diversity of the <italic>KIR</italic> locus is formed through recombination events that duplicate or delete entire genes, or deletions that create in-frame gene fusions (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). This genetic variation thus has direct consequences for NK cell functions, which are further diversified by the alleles of KIR and their HLA class I ligands (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Within HLA-A, B and C, only those allotypes that contain one of four amino acid motifs, termed A3/11, Bw4, C1 or C2, in the external-facing &#x3b1;-helices can be ligands for KIR. Polymorphism both within and outside these motifs diversifies the interactions of KIR with HLA and individualize NK cell functions (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). There are two broad forms of <italic>KIR</italic> haplotype, termed <italic>KIR-A</italic> and <italic>KIR-B</italic> (<xref ref-type="bibr" rid="B23">23</xref>). <italic>KIR-A</italic> haplotypes have fixed gene content, encoding four inhibitory KIR specific for HLA-A, B or C, as well as KIR2DS4, which is an activating receptor specific for some HLA-A and C allotypes (<xref ref-type="bibr" rid="B24">24</xref>). The majority of <italic>KIR2DS4</italic> alleles are not expressed due to a deletion in exon 5 (<xref ref-type="bibr" rid="B25">25</xref>). <italic>KIR-B</italic> haplotypes contain a variable number of genes for activating KIR and fewer for inhibitory KIR. The two haplotype groups display distinct functional characteristics. For example, although KIR2DL2 and KIR2DL3 are encoded by the same locus, they differ in strength and specificity and characterize <italic>KIR-B</italic> and <italic>KIR-A</italic> haplotypes, respectively (<xref ref-type="bibr" rid="B26">26</xref>). Accordingly, <italic>KIR-A</italic> and <italic>KIR-B</italic> haplotypes also have distinct disease association profiles (<xref ref-type="bibr" rid="B27">27</xref>). <italic>KIR-A</italic> haplotypes associate with effective immunity against acute viral infections, but with increased risk of preeclampsia during pregnancy (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). <italic>KIR-B</italic> haplotypes protect women from this pregnancy disorder and improve the outcome of hematopoietic stem cell transplantation (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Additional to the <italic>KIR-A</italic> and <italic>KIR-B</italic> haplotype designations, specific alleles that can be characteristic to the haplotypes associate with disease susceptibility or protection. A total of 1,110 alleles encoding 543 allotypes have been reported according to the IPD-KIR database release version 2.10.0 (<xref ref-type="bibr" rid="B32">32</xref>).</p>
<p>The development of next-generation sequencing (NGS) technologies for genotyping <italic>KIR</italic> and <italic>HLA</italic> at high-resolution has helped identify the substantial variation of KIR allotypes and their interactions with HLA ligands across human populations (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>). It is therefore of great significance to characterize this combinatorial diversity across all human populations. Although China, as one of the four ancient civilizations of the world, accounts for approximately 20% of the human population, analysis of the <italic>KIR</italic> locus at high-resolution from East Asia is limited to two studies (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). In this study, we fully characterize the allele, haplotype and combinatorial diversity of <italic>KIR</italic> and <italic>HLA class I</italic> in the Zhejiang Han population from the Southeast coast of China (27&#xb0;02&#x2019; to 31&#xb0;11&#x2019; North, 118&#xb0;01&#x2019; to 123&#xb0;10&#x2019; East).</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Samples and DNA Extraction</title>
<p>176 blood samples were collected from healthy blood donors in the Blood Center of Zhejiang province, China. The ethnic background of all individuals is Zhejiang Han. Informed consent was obtained from all participants. The Zhejiang Han are a population of approximately 60 million individuals living on the Southeast coast of China and are a subgroup of the Chinese Southern Han ethnic group. This study was approved by the regional ethics committee, Blood Center of Zhejiang Province. Genomic DNA was extracted using MagNA Pure LC DNA Isolation Kits (Roche Diagnostics, Indianapolis, IN, USA) according to the manufacturer&#x2019;s instructions. The final DNA concentration was adjusted to 60 ng/&#x3bc;l and optical density at 260/280 was approximately 1.8.</p>
</sec>
<sec id="s2_2">
<title>High-Resolution Sequencing for <italic>KIR</italic> and <italic>HLA</italic>
</title>
<p>A biotinylated DNA probe-based capture method was applied to sequence <italic>KIR</italic> and <italic>HLA</italic> genes to high-resolution, as described previously (<xref ref-type="bibr" rid="B33">33</xref>). Briefly, 500 ng genomic DNA for each sample was randomly fragmented using enzyme digestion (New England Biolabs, Boston, MA) and then labeled with TruSeq DNA CD indexes (Illumina Inc, San Diego, CA). Fragments of 800&#x2013;1,200 bp length were obtained by size selection and the individual samples pooled at equal quantity into one tube. Fragments containing target <italic>HLA</italic> and <italic>KIR</italic> genes were captured using specific probes, prepared to a final concentration of 12 pmol/L, as determined by Qubit instrument, then sequenced using a MiSeq instrument and a v3 Reagent Kit (600-cycle; Illumina Inc, San Diego, CA, USA).</p>
</sec>
<sec id="s2_3">
<title>Sequence Data Analysis</title>
<p>
<italic>KIR</italic> gene content, copy numbers, and allele genotypes were determined using the Pushing Immunogenetics to the Next Generation pipeline (PING) as previously reported (<xref ref-type="bibr" rid="B33">33</xref>). The copy number was determined from the ratio of reads mapping to each <italic>KIR</italic> gene to those mapping to <italic>KIR3DL3</italic>, a reference gene present only one copy on each haplotype. Alleles for 13 <italic>KIR</italic> genes were analyzed, of which <italic>KIR2DL2</italic> and <italic>KIR2DL3</italic> are alleles at the same locus (<italic>KIR2DL2/3</italic>), as are <italic>KIR2DS3</italic> and <italic>KIR2DS5</italic> (<italic>KIR2DS3/5</italic>), and <italic>KIR3DL1</italic> and <italic>KIR3DS1</italic> (<italic>KIR3DL1/S1</italic>). <italic>KIR3DL3</italic> alleles were determined using PHASE 2.1 (<xref ref-type="bibr" rid="B38">38</xref>). The <italic>HLA</italic> alleles were determined using TypeStream Visual NGS Analysis Software (TSV2.0, One Lambda Inc, Canoga Park, CA). The presence of KIR ligands, A3/11, Bw4, and C1/C2 was determined according to the <italic>HLA</italic> alleles.</p>
</sec>
<sec id="s2_4">
<title>Frequencies of Alleles, Genotypes, and Haplotypes</title>
<p>
<italic>KIR</italic> genotypes were named based on the presence or absence of <italic>KIR</italic> genes according to the allelefrequencies.net database (<xref ref-type="bibr" rid="B39">39</xref>). Carrier frequencies of <italic>KIR</italic> genes and genotypes were calculated as their percentage of the total number of individuals. The frequencies of alleles or haplotypes were calculated by direct counting, and the number observed divided by 2N (alleles duplicated on a single haplotype were not included, and absence was counted as a distinct allele). The composition and frequencies of <italic>HLA</italic> haplotypes were determined using Arlequin 3.5.2.2 (<xref ref-type="bibr" rid="B40">40</xref>).</p>
</sec>
<sec id="s2_5">
<title>KIR/HLA Interaction Analysis</title>
<p>Interactions between inhibitory KIR and HLA ligands were analyzed. The number of distinct allotype interactions was counted for each KIR for every individual and the mean number was calculated per population. Broadly, KIR2DL1 recognizes C2<sup>+</sup>HLA-C, and KIR2DL2/3 recognizes C1<sup>+</sup>HLA-C, and some C2<sup>+</sup>HLA-C. KIR3DL1 recognizes the Bw4 motif at residues 77&#x2013;80 of some HLA-A and HLA-B allotypes. KIR3DL2 recognizes the A3/11 motif carried by HLA-A*03 and HLA-A*11 allotypes (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). Major exceptions are KIR2DL1*022, which interacts with C1<sup>+</sup>HLA, and HLA-B*46 and B*73, which carry C1 motifs (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B26">26</xref>).</p>
</sec>
<sec id="s2_6">
<title>Statistical Analysis</title>
<p>Hardy&#x2013;Weinberg equilibrium (HWE) was determined for each gene using Fisher&#x2019;s exact test implemented in the Arlequin software 3.5.2.2. The distributions of genes, alleles, haplotypes, and KIR/HLA interactions in the Zhejiang Han population were compared to other populations as described. Differences between populations were assessed using GraphPad software, by means of the &#x3c7;<sup>2</sup> test for categorical variables. The p values were calculated using Fisher&#x2019;s exact test (pf), applied when appropriate. Bonferroni correction for multiple comparisons was applied. p&#xa0;&lt;0.05 was regarded as significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>High Frequency of <italic>KIR-A</italic> Haplotypes in Zhejiang Han</title>
<p>To analyze the <italic>KIR</italic> locus of the Zhejiang Han at high resolution, we first established which <italic>KIR</italic> genes are present, and in how many copies, for every individual. The four framework genes [<italic>KIR3DL3</italic>, <italic>KIR2DL4</italic>, <italic>KIR3DP1</italic> and <italic>KIR3DL2</italic> (<xref ref-type="bibr" rid="B15">15</xref>)] were detected in all 176 individuals of the cohort (<xref ref-type="fig" rid="f1">
<bold>Figure 1A</bold>
</xref>). <italic>KIR2DL4</italic> and <italic>KIR3DP1</italic> were each observed with one to three copies and one individual in the cohort has only one copy of <italic>KIR3DL2</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure 1A</bold>
</xref>). Only four individuals have less than two copies of any of these framework genes, six individuals harbor three copies, and none were observed with four copies. These observations indicate that, although structural diversity of the <italic>KIR</italic> locus is present, it is rare in the Zhejiang Han population. <italic>KIR2DL1, KIR2DL3, KIR3DL1, KIR2DS4</italic>, and <italic>KIR2DP1</italic> were all observed at a frequency greater than 90% and at two copies in at least 64.8% of the population (<xref ref-type="fig" rid="f1">
<bold>Figures 1A, B</bold>
</xref>
<bold>)</bold>. These five genes are not present on every <italic>KIR</italic> haplotype, and when they occur together, they characterize the <italic>KIR A</italic> haplotype (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B51">51</xref>)<italic>. KIR2DL3</italic>, which occurs in the centromeric <italic>KIR</italic> region, showed higher frequency than <italic>KIR3DL1</italic> and <italic>KIR2DS4</italic>, which are located in the telomeric <italic>KIR</italic> region (81.8% vs 64.8%), indicating a higher frequency of centromeric <italic>KIR-A</italic> haplotype motifs (<italic>Cen-A</italic>) than telomeric <italic>KIR-A</italic> motifs (<italic>Tel-A</italic>). Accordingly, the genes characteristic of <italic>KIR-B</italic> haplotypes have frequencies less than 25% in centromeric and approximately 35% in telomeric <italic>KIR</italic> region (<xref ref-type="fig" rid="f1">
<bold>Figure 1B</bold>
</xref>). We compared the distribution of <italic>KIR</italic> genes of Zhejiang Han with populations representing Asia (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B52">52</xref>&#x2013;<xref ref-type="bibr" rid="B54">54</xref>), Europe (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>), Africa (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B57">57</xref>), America (<xref ref-type="bibr" rid="B50">50</xref>) and Oceania (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>) (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Table 1</bold>
</xref>). As a control, this analysis showed the <italic>KIR</italic> gene frequencies to be similar to our previous study of an independent Zhejiang Han cohort that was performed at lower resolution (<xref ref-type="bibr" rid="B60">60</xref>). The <italic>KIR</italic> gene frequencies are also similar to those of other populations from East Asia including Japan (<xref ref-type="bibr" rid="B37">37</xref>), South Korea (<xref ref-type="bibr" rid="B43">43</xref>) and Singapore (<xref ref-type="bibr" rid="B53">53</xref>), but distinct from Southeast Asians (<xref ref-type="bibr" rid="B46">46</xref>) and populations from other continents (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Table 1</bold>
</xref>). Accordingly, the frequencies of <italic>Cen-B</italic> specific <italic>KIR</italic> genes (<italic>KIR2DS2, KIR2DL2</italic>, <italic>KIR2DL5B</italic>) in the Zhejiang Han are significantly lower than all populations outside East Asia (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Table 1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Distribution of genotypes derived from 176 Zhejiang Han individuals. <bold>(A)</bold> Shown for each <italic>KIR</italic> gene is the frequency (%) of individuals carrying the number of copies indicated at the left (0&#x2013;3). Dash &#x201c;&#x2013;&#x201d; represents not observed. The four framework genes are indicated in bold text. <bold>(B)</bold> Shown is the percentage of <italic>KIR-A</italic> and <italic>KIR-B</italic> haplotypes that carry each of the genes indicated. Shades of red to black represent the percentages, and the key is shown at the right. <bold>(C)</bold> Shown are <italic>KIR</italic> gene content genotypes observed in the Zhejiang Han individuals. The colors of the boxes indicate the gene copy numbers, as given in the key at the right. Genotype IDs based on the presence or absence of <italic>KIR</italic> genes (<xref ref-type="bibr" rid="B39">39</xref>) are shown on the left. The frequencies (%) of the corresponding genotypes are listed in the right. <bold>(D)</bold> Shown are the carrier frequencies of <italic>KIR</italic> gene content genotypes <italic>-AA1</italic>, <italic>Bx2</italic>, <italic>Bx3</italic>, <italic>Bx4</italic>, <italic>Bx5</italic>, <italic>Bx8</italic> in ten different populations. They are Chinese Southern Han from Shenzhen (<xref ref-type="bibr" rid="B36">36</xref>), Japanese (<xref ref-type="bibr" rid="B37">37</xref>), South Korean (<xref ref-type="bibr" rid="B43">43</xref>), Taiwan Chinese (<xref ref-type="bibr" rid="B44">44</xref>), Malay (<xref ref-type="bibr" rid="B45">45</xref>), Thai (<xref ref-type="bibr" rid="B46">46</xref>), Europeans (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>), Sub-Saharan Africans Ghanaians (<xref ref-type="bibr" rid="B49">49</xref>) and South American Yucpa (<xref ref-type="bibr" rid="B50">50</xref>). The colored circles represent the populations, as shown at the right.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-640334-g001.tif"/>
</fig>
<p>As determined by the copy number of each of the 13 <italic>KIR</italic> genes, twenty-three distinct genotypes were observed (<xref ref-type="fig" rid="f1">
<bold>Figure 1C</bold>
</xref>). Of these genotypes, <italic>KIR-AA</italic> is the most frequent (53.4%) in Zhejiang Han (<xref ref-type="fig" rid="f1">
<bold>Figure 1C</bold>
</xref>). The <italic>KIR-AA</italic> genotype is common across East Asia, also being observed frequently in other Chinese Southern Han (<xref ref-type="bibr" rid="B36">36</xref>), Taiwan Chinese (<xref ref-type="bibr" rid="B44">44</xref>), South Korean (<xref ref-type="bibr" rid="B43">43</xref>), and Japanese (<xref ref-type="bibr" rid="B37">37</xref>). The <italic>KIR-AA</italic> genotype is less frequent outside East Asia, as illustrated by populations representing Southeast Asia, Europe, South America, and sub-Saharan Africa (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>). The other 22 <italic>KIR</italic> genotypes observed in Zhejiang Han are designated <italic>KIR-Bx</italic>, the distributions of which are also similar among East Asians and distinct from populations of other continents (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>). For example, <italic>Bx2</italic>, which is the most frequent <italic>KIR-B</italic> genotype in Zhejiang Han, was not observed in sub-Saharan Africans, whereas <italic>Bx5</italic> is frequent in sub-Saharan Africans, but very rare in Zhejiang Han (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>). Another example is <italic>Bx3</italic>, which was observed with high frequency in Amerindians, but almost absent from all other populations (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>). These examples of distinct genotype profiles characterizing major human population groups illustrate the rapid evolution of the <italic>KIR</italic> locus (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B61">61</xref>).</p>
</sec>
<sec id="s3_2">
<title>Genes for Inhibitory KIR Exhibit More Allelic Diversity Than Those for Activating KIR</title>
<p>A total of 107 <italic>KIR</italic> alleles were observed in the Zhejiang Han cohort (<xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Table 2</bold>
</xref>) and no novel alleles were identified. The allele frequency distributions for all the <italic>KIR</italic> genes were in accordance with Hardy&#x2013;Weinberg equilibrium. The inhibitory KIR are more diverse and polymorphic (88 alleles in total) than the activating KIR (14 alleles). The most diverse gene encoding an activating KIR is <italic>KIR2DS4</italic>, which is the only activating KIR carried by the <italic>KIR-A</italic>&#xa0;haplotype, with five alleles observed (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>). <italic>KIR2DS4*00101</italic> is the most frequent allele and is the only one that can encode a functional allotype on the cell surface, whereas the remainder are non-expressed alleles because of a 22bp deletion in exon 5 (<xref ref-type="bibr" rid="B25">25</xref>). Other activating KIR are encoded by <italic>KIR-B</italic> haplotypes and show little diversity. <italic>KIR2DS3/5</italic> can be present on either a <italic>Cen-B</italic> or <italic>Tel-B</italic> haplotype; two <italic>KIR2DS3</italic> alleles were observed, one is <italic>KIR2DS3*00103</italic> observed in <italic>Cen-B</italic>, and the other is <italic>KIR2DS3*00201</italic> observed in <italic>Tel-B.</italic> Although the activating KIR are less polymorphic, their allele frequency distributions do vary across populations. For example in Zhejiang Han, functional KIR2DS4 allotypes are the most frequent, whereas in some populations, such as in Oceania (<xref ref-type="bibr" rid="B62">62</xref>), the non-expressed <italic>KIR2DS4</italic> alleles predominate.</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>KIR alleles present in the Zhejiang Han population. <bold>(A)</bold> Shown is the total number of <italic>KIR</italic> alleles observed in 176 Zhejiang Han. Genes encoding inhibitory KIR are indicated by red bars, activating by blue bars, and pseudogenes by gray bars. <bold>(B)</bold> Shown are the ratios of expressible and non-expressed alleles of KIR2DS4 and KIR2DL4 in Zhejiang Han. Each pie segment represents a distinct allele, orange indicates allele can be expressed at the cell surface, blue indicates not expressed, grey indicates gene absent. <bold>(C)</bold> Shown is the KIR3DL1 allele expression frequency spectrum in Zhejiang Han. Magenta indicates high expression alleles, cyan&#x2014;low expression, green&#x2014;KIR3DS1 (activating receptor) and gray indicates gene absence or unknown expression pattern.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-640334-g002.tif"/>
</fig>
<p>Among genes encoding inhibitory KIR, those with three domains show greatest variability (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B32">32</xref>). We observed 23 alleles each of <italic>KIR3DL3</italic> and <italic>KIR3DL2</italic> and 11 alleles of <italic>KIR3DL1/S1</italic>, which encode 16, 17, and 11 allotypes, respectively (<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Table 2</bold>
</xref>). Thus, each allele of <italic>KIR3DL1</italic> we observed here (<xref ref-type="fig" rid="f2">
<bold>Figure 2C</bold>
</xref>) encodes a distinct allotype and the most abundant have high-expressing, high-binding, phenotypes (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B63">63</xref>, <xref ref-type="bibr" rid="B64">64</xref>). KIR3DL1*015 is the most frequent KIR3DL1 allotype in Zhejiang Han. Comparison with other representative populations shows that KIR3DL1*015 is present worldwide, reaching highest frequency in East Asians (<xref ref-type="fig" rid="f3">
<bold>Figure 3</bold>
</xref>). By contrast, KIR3DL1*004, which is a poorly expressed phenotype found in Europeans and Africans, was not observed in Zhejiang Han (<xref ref-type="fig" rid="f3">
<bold>Figure 3</bold>
</xref>) and neither was it observed in another Chinese Southern Han group (<xref ref-type="bibr" rid="B36">36</xref>). We previously reported <italic>KIR3DL1</italic> allele frequencies from an independent cohort of Zhejiang Han (<xref ref-type="bibr" rid="B66">66</xref>). Because <italic>KIR3DS1</italic> was not analyzed in that cohort, the reported <italic>KIR3DL1</italic> allele frequencies are higher than in the present cohort, however, the frequencies are similar when <italic>KIR3DS1</italic> is considered. The present analysis also showed that <italic>KIR3DL3</italic> has the most extensive cross-population diversity. Here, KIR3DL3*010 clearly characterizes East Asian populations, whereas 3DL3*003 for example characterizes Amerindians, but is rare in East Asians (<xref ref-type="fig" rid="f3">
<bold>Figure 3</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure 3</label>
<caption>
<p>KIR allotype diversity across human populations. Shown are the frequencies of KIR3DL1-3, KIR2DL1-4, and KIR2DS4 allotypes from seven human populations. Shades of dark blue to dark red represent the allotype frequencies from low to high as indicated in the key at the bottom. Zhe, Zhejiang Han; SZ, Shenzhen Han (<xref ref-type="bibr" rid="B36">36</xref>); Eur, European (<xref ref-type="bibr" rid="B65">65</xref>); Mao, M&#x101;ori (<xref ref-type="bibr" rid="B62">62</xref>); Mal, Malay (<xref ref-type="bibr" rid="B45">45</xref>); Kho, Southern Africa Khomani (<xref ref-type="bibr" rid="B34">34</xref>); Gha, sub-Saharan Africa Ghanaian (<xref ref-type="bibr" rid="B49">49</xref>); Yuc, Amerindian Yucpa (<xref ref-type="bibr" rid="B50">50</xref>). For KIR2DL4, the sum of expressible allotypes is shown. * standard WHO nomenclature for KIR alleles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-640334-g003.tif"/>
</fig>
<p>Although KIR2DL1 is the most polymorphic two-domain KIR, having 173 known alleles [IPD-IMGT/KIR Database version 2.10.0, December 2020 (<xref ref-type="bibr" rid="B32">32</xref>)], it has low diversity in Zhejiang Han, with five alleles observed (<xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref>). The most prominent of these alleles is <italic>KIR2DL1*00302</italic> at an allele frequency of 77.8% (<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Table 2</bold>
</xref>), corresponding with a similar frequency of <italic>KIR2DL3*00101.</italic> This strong linkage disequilibrium between the two alleles is shared across multiple populations worldwide (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B65">65</xref>). KIR2DL4, which can be an activating receptor specific for HLA-G (<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>), has six alleles in Zhejiang Han (<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Table 2</bold>
</xref>). Of 107 <italic>KIR2DL4</italic> alleles, encoding 54 distinct polypeptide sequences, 18 do not express a receptor on the cell surface due to a single nucleotide deletion at position 811 in Exon 7 (<xref ref-type="bibr" rid="B69">69</xref>). The non-expressed alleles include <italic>KIR2DL4*008</italic> and <italic>KIR2DL4*011</italic>, which were observed at a total frequency of 20.2% in Zhejiang Han (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>). The four expressible <italic>KIR2DL4</italic> alleles observed thus constitute a majority. This majority varies little across human populations, the most extreme being Amerindians, where &gt;95% <italic>KIR2DL4</italic> alleles are expressible, and the exception being KhoeSan, where there is an approximately equal ratio between expressible and non-expressible forms of <italic>KIR2DL4</italic> (<xref ref-type="fig" rid="f3">
<bold>Figure 3</bold>
</xref>).</p>
</sec>
<sec id="s3_3">
<title>
<italic>KIR-A</italic> Haplotypes Are More Frequent Than <italic>KIR-B</italic> Haplotypes Both in Centromeric and Telomeric Regions</title>
<p>Based on the copy number and allele information obtained from high resolution analysis, 54 centromeric haplotypes and 37 telomeric haplotypes were observed in Zhejiang Han (<xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Table 3</bold>
</xref>). As defined by gene content, three common centromeric haplotype groups, <italic>cA01</italic>, <italic>cB01</italic>, and <italic>cB02</italic>, and two telomeric groups, <italic>tA01</italic> and <italic>tB01</italic>, were observed, as well as rarer forms having duplicated or deleted segments (<xref ref-type="fig" rid="f4">
<bold>Figure 4</bold>
</xref>). When accounting for allele diversity, there are 41 haplotypes in the <italic>cA01</italic> group (<xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Table 3A</bold>
</xref>), and 23 in the <italic>tA01</italic> group (<xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Table 3B</bold>
</xref>). The most frequent <italic>cA01</italic> haplotype at the allele level in Zhejiang Han is <italic>KIR3DL3*01002-2DL3*00101-2DP1*00201-2DL1*00302</italic>, with a frequency of 19.03% (<xref ref-type="fig" rid="f5">
<bold>Figure 5A</bold>
</xref>). The five most common <italic>cA01</italic> haplotypes (64.5% in total) differ only in their <italic>KIR3DL3</italic> alleles (<xref ref-type="fig" rid="f5">
<bold>Figure 5A</bold>
</xref>). The high polymorphism of <italic>KIR3DL3</italic> alleles diversifies the centromeric region, and the number of the centromeric haplotypes would decrease from 54 to 19 if <italic>KIR3DL</italic>3 alleles were excluded (<xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Table 3A</bold>
</xref>). The most frequent <italic>tA01</italic> haplotype at the allele level in Zhejiang Han is <italic>KIR2DL4*00102-3DL1*01502-2DS4*00101-3DL2*00201</italic> (<xref ref-type="fig" rid="f5">
<bold>Figure 5B</bold>
</xref>), with a frequency of 45.5%. Within the telomeric haplotypes, <italic>KIR2DS3/5t</italic> and <italic>KIR2DL5A</italic> alleles show strong linkage disequilibrium, in which <italic>KIR2DS5*00201</italic> and <italic>KIR2DL5A*00101</italic> are always found together, as are <italic>KIR2DS3*00201</italic> and <italic>KIR2DL5A*00501</italic>. These patterns of linkage disequilibrium are the same as those found in other populations outside of Africa.</p>
<fig id="f4" position="float">
<label>Figure 4</label>
<caption>
<p>Distribution of <italic>Cen-A/B</italic> and <italic>Tel-A/B</italic> haplotypes in the Zhejiang Han.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-640334-g004.tif"/>
</fig>
<fig id="f5" position="float">
<label>Figure 5</label>
<caption>
<p>
<italic>KIR</italic> haplotypes identified in 176 Zhejiang Han. <bold>(A, B)</bold>. Shown are the ten most frequent centromeric and telomeric haplotypes and their frequencies observed in Zhejiang Han. <bold>(C)</bold> Shown are the extended telomeric haplotypes observed in Zhejiang Han. <bold>(D)</bold> Shown are the two complete haplotypes for each of the five individuals who exhibit contracted <italic>KIR</italic> haplotypes. <italic>KIR-A</italic> haplotype are shaded red and <italic>KIR-B</italic> haplotypes are blue. Gray indicates insertion. Yellow indicates deletion. Blank boxes indicate gene absence. The frequencies of haplotypes are shown at the right. * standard WHO nomenclature for KIR alleles.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-640334-g005.tif"/>
</fig>
<p>Six individuals having an insertion/duplication of <italic>KIR3DP1-2DL4-3DS1</italic> were observed in Zhejiang Han (<xref ref-type="fig" rid="f5">
<bold>Figure 5C</bold>
</xref>). The corresponding haplotypes comprised two distinguished at the gene content level, and three as determined by allele content. We also identified four individuals with haplotypes lacking <italic>KIR3DP1-2DL4-3DL1/S1</italic> (<xref ref-type="fig" rid="f5">
<bold>Figure 5D</bold>
</xref>), with three of these haplotypes (individuals 1, 2 and 4: <xref ref-type="fig" rid="f5">
<bold>Figure 5D</bold>
</xref>) distinguished only by their alleles of <italic>KIR3DL3</italic>. These haplotypes likely formed by uneven exchange during meiotic recombination, and have also been observed in other populations (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>). Although it remains to be confirmed through full haplotype sequence analysis, the insertions/duplications and the deletions occur in approximately the same location 5&#x2019; from <italic>KIR3DP1</italic>, suggesting the crossovers can occur frequently through shared mechanisms (<xref ref-type="bibr" rid="B72">72</xref>). In addition, we identified a unique haplotype that lacks any <italic>KIR</italic> genes in the telomeric region 3&#x2019; from <italic>KIR2DL4</italic>, leaving only six genes on the entire <italic>KIR</italic> haplotype (individual 5; <xref ref-type="fig" rid="f5">
<bold>Figure 5D</bold>
</xref>). That the allele is <italic>KIR2DL4*00102</italic> suggests the parental haplotype that lost these genes was similar to the most frequent <italic>KIR-A</italic> in Zhejiang Han (<xref ref-type="fig" rid="f5">
<bold>Figure 5B</bold>
</xref>).</p>
</sec>
<sec id="s3_4">
<title>High Frequency of Strong Inhibitory <italic>KIR/HLA</italic> Interactions Identified in Zhejiang Han</title>
<p>Alleles for highly polymorphic HLA-class I (<italic>HLA-A</italic>, <italic>-B</italic>, <italic>-C</italic>) were obtained from high resolution sequencing. A total of 25 <italic>HLA-A</italic> alleles, 43 <italic>HLA-B</italic> alleles, and 27 <italic>HLA-C</italic> alleles were observed (<xref ref-type="supplementary-material" rid="SF4">
<bold>Supplementary Table 4</bold>
</xref>), and the distributions for all the <italic>HLA</italic> genes complied with Hardy&#x2013;Weinberg equilibrium. Only some HLA-class I allotypes act as ligands for KIR (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B27">27</xref>). The two most frequent alleles of <italic>HLA-A</italic>, <italic>-B</italic>, <italic>-C</italic> respectively in Zhejiang Han are <italic>A*11:01</italic> (25.3%) and <italic>A*24:02</italic> (13.1%), <italic>B*40:01</italic> (11.6%) and <italic>B*46:01</italic> (10.5%), <italic>C*07:02</italic> (18.2%) and <italic>C*01:02</italic> (16.8%). All the allotypes they encode can interact with KIR, except for B*40:01. Every HLA-C allotype is a ligand for <italic>KIR</italic>, and in total, 44.1% of HLA-A and 48.6% of HLA-B allotypes by frequency in the Zhejiang Han can act as KIR ligands (<xref ref-type="fig" rid="f6">
<bold>Figures 6A, B</bold>
</xref>). Most of the HLA-C allotypes (82.4%) contain a C1 motif (C1<sup>+</sup>HLA-C) in Zhejiang Han and <italic>HLA-B*46:01</italic>, which also carries a C1 motif was also observed at high frequency (10.5%). HLA-B*46:01 is one of only two HLA-B allotypes that carry a C1 motif (C1<sup>+</sup>HLA-B), the other is HLA-B*73:01, and both have geographical distributions focused in Asia, B*46:01 in Southeast Asia and B*73:01 in West Asia (<xref ref-type="bibr" rid="B39">39</xref>). C1<sup>+</sup>HLA-C and C1<sup>+</sup>HLA-B were both observed at higher frequencies than non-Asian populations (<xref ref-type="fig" rid="f6">
<bold>Figure 6C</bold>
</xref>). Accordingly, HLA-C2 shows extremely low frequency in Zhejiang Han, and significantly lower than other populations (<xref ref-type="fig" rid="f6">
<bold>Figure 6C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SF5">
<bold>Supplementary Table 5</bold>
</xref>). Moreover, A3/11, specifically encoded by <italic>A*11:01</italic>, was observed at higher frequency in Zhejiang Han than any other populations. We identified 166 <italic>HLA</italic> haplotypes (<xref ref-type="supplementary-material" rid="SF4">
<bold>Supplementary Table 4</bold>
</xref>). Most of the observed haplotypes (77.3%) encode more than two KIR ligands, including A*11:01, which was detected in five of the ten most frequent haplotypes (<xref ref-type="fig" rid="f6">
<bold>Figure 6D</bold>
</xref>). These findings are similar to those recently reported for Chinese Southern Han from Shenzhen (<xref ref-type="bibr" rid="B36">36</xref>).</p>
<fig id="f6" position="float">
<label>Figure 6</label>
<caption>
<p>The distribution of HLA in Zhejiang Han. <bold>(A)</bold> Shown are the frequency spectra of <italic>HLA-A</italic>, <italic>-B</italic>, and <italic>-C</italic> allotypes from 176 Zhejiang Han individuals. Each pie segment represents a distinct allotype (HLA allotype frequencies are given in <xref ref-type="supplementary-material" rid="SF4">
<bold>Supplementary Table 4</bold>
</xref>), colored segments signify the allotypes that are KIR ligands: Yellow&#x2014;A3/11 (HLA-A3 and -A11); Green&#x2014;Bw4; Red&#x2014;C1; Blue&#x2014;C2; Gray&#x2014;allotypes that are not KIR ligands. <bold>(B)</bold> Shown are the numbers of distinct allotypes observed and the combined frequencies of A3/11, Bw4, C1, or C2 allotypes for each HLA class I gene. <bold>(C)</bold> Shown are the distributions of KIR ligands across seven representative populations. The allotype are shown at the bottom. The populations are listed at the right: Chinese Southern Han from Shenzhen, Japanese, South American Yucpa, European, Sub-Saharan African, and Oceania Polynesian (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B65">65</xref>). <bold>(D)</bold> (Left) Shown are the combined frequencies in Zhejiang Han of <italic>HLA class I</italic> haplotypes encoding one (lilac), two (pink) or three (purple) KIR ligands. (Right) the ten most frequent <italic>HLA class I</italic> haplotypes observed, colored shading indicates <italic>HLA class I</italic> alleles that encode KIR ligands, as described in panel <bold>(A)</bold>. <bold>(E)</bold> Shown is the mean number of distinct interactions per individual observed for each of the inhibitory KIR that interact with polymorphic HLA class I. From left to right: KIR2DL1 interactions with C2<sup>+</sup>HLA-C [or with C1<sup>+</sup>HLA-C for KIR2DL1*022 allotype (<xref ref-type="bibr" rid="B20">20</xref>)] KIR2DL2 with C1<sup>+</sup>HLA-B or C, or with C2<sup>+</sup>HLA-C; KIR2DL3 with C1<sup>+</sup>HLA-B or C; KIR3DL1 with Bw4<sup>+</sup>HLA-A or B; KIR3DL2 with HLA-A3/11. The values are shown for nine representative populations: Southern Africa Khomani (<xref ref-type="bibr" rid="B34">34</xref>); sub-Saharan Africa Ghanaian (<xref ref-type="bibr" rid="B49">49</xref>); European (<xref ref-type="bibr" rid="B65">65</xref>); Malay (<xref ref-type="bibr" rid="B45">45</xref>); M&#x101;ori (<xref ref-type="bibr" rid="B62">62</xref>); Zhejiang Han; Shenzhen Han (<xref ref-type="bibr" rid="B36">36</xref>); Amerindian Yucpa (<xref ref-type="bibr" rid="B50">50</xref>); Japanese (<xref ref-type="bibr" rid="B37">37</xref>). <bold>(F)</bold> Shown is the frequency of <italic>HLA-B</italic> alleles encoding methionine (orange) or threonine (gray) at position -21 in the leader peptide. Each pie segment represents a distinct HLA-B allotype (HLA allotype frequencies are given in <xref ref-type="supplementary-material" rid="SF4">
<bold>Supplementary Table 4</bold>
</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-640334-g006.tif"/>
</fig>
<p>The high frequency of the <italic>KIR-A</italic> haplotype, which encodes four inhibitory receptors able to interact with HLA class I ligands (KIR2DL3, KIR2DL1, KIR3DL1 and KIR3DL2), indicates inhibitory KIR-HLA interactions predominate in Zhejiang Han. Here, <italic>KIR2DL1*00302</italic>, <italic>KIR2DL3*00101</italic>, <italic>KIR3DL1*01502</italic> and <italic>KIR3DL2*00201</italic> are the major alleles carried by the <italic>KIR-A</italic> haplotype, and all the allotypes they encode have strong interactions with their HLA ligands compared to other allotypes (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). Because of the high frequency of <italic>KIR-A</italic>, Zhejiang Han are rich in <italic>KIR-AA</italic> genotypes, and each of these individuals therefore has eight strong inhibitory KIR allotypes that can interact with HLA. The mean number of inhibitory KIR-HLA pairs per individual was analyzed, revealing that the mean interaction of KIR2DL3-C1<sup>+</sup>HLA per individual (2.2) is higher than other populations (<xref ref-type="fig" rid="f6">
<bold>Figure 6E</bold>
</xref>). This high frequency is caused by the high frequencies of KIR2DL3 and C1<sup>+</sup>HLA-C, and the extra C1<sup>+</sup>HLA-B allotype present (<xref ref-type="fig" rid="f6">
<bold>Figure 6A</bold>
</xref>). By contrast, due to the low frequency of the C2<sup>+</sup>HLA-C allotypes, the frequency of interactions with C2<sup>+</sup>HLA is low in Zhejiang Han (<xref ref-type="fig" rid="f6">
<bold>Figure 6E</bold>
</xref>). In these regards the Zhejiang Han also show very similar repertoires to the Shenzhen Chinese Southern Han (<xref ref-type="bibr" rid="B36">36</xref>). Further diversifying NK cell interactions with polymorphic HLA, conserved HLA-E can present peptides derived from HLA-A, C and some B allotypes. The peptides are derived from allotypes possessing methionine at the second residue of the leader sequence (-21M). HLA-E is recognized by inhibitory CD94:NKG2A expressed by NK cell and T cell subsets (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>). In Zhejiang Han, the total frequency of <italic>HLA-B</italic> alleles encoding -21M is 11.6% (<xref ref-type="fig" rid="f6">
<bold>Figure 6F</bold>
</xref>). Among them, only <italic>HLA-B*38</italic> also encodes a Bw4 ligand for KIR and is the most frequent at 3.7%.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Specific genetic variants of KIR, HLA, and their combinations are associated with susceptibility and progression of multiple immune-mediated diseases, including viral infections, autoimmunity, cancer and reproductive disorders (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Critical to understanding these disease mechanisms are systematic analyses of KIR and HLA allotype diversity across defined human populations. In this study, we used a targeted sequencing method to comprehensively characterize all <italic>KIR</italic> and <italic>HLA class I</italic> alleles at high resolution for the Zhejiang Han, who represent the Chinese Southern Han on the Southeastern coast of China. From 176 healthy individuals we identified 23 <italic>KIR</italic> gene-content genotypes, 107 <italic>KIR</italic> alleles, 54 centromeric and 37 telomeric <italic>KIR</italic> haplotypes, and 11 individuals having evidence for large scale gene rearrangements. We also observed 95 HLA class I allotypes, encoded by 166 distinct <italic>HLA-A-B-C</italic> haplotypes. We show that the Zhejiang Han are characterized by a predominance of interactions of strongly inhibitory KIR with HLA class I, and particularly KIR2DL3 with C1<sup>+</sup>HLA, supporting the observation that these inhibitory interactions are significantly enhanced in East Asians (<xref ref-type="bibr" rid="B36">36</xref>). Because strongly-inhibiting KIR enable maturation of NK cells with strong effector functions (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B77">77</xref>), one expected consequence is that NK cell responses are enhanced in East Asians relative to other populations.</p>
<p>As observed in other East Asian populations (<xref ref-type="bibr" rid="B39">39</xref>), we identified a high frequency of <italic>KIR-A</italic> haplotypes in Zhejiang Han, where more than 90% of centromeric and 80% telomeric haplotypes have the <italic>KIR-A</italic> configuration. Previous whole-genome, as well as analyses focused on the <italic>KIR</italic> genomic region, have shown that the centromeric <italic>KIR-A</italic> haplotypes are subject to positive natural selection specifically in East Asians (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>). By contrast, other studies continue to identify a balance between <italic>KIR-A</italic> and <italic>KIR-B</italic> haplotypes across populations worldwide, likely due to competing influences from infection control and reproduction (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B80">80</xref>). Another outcome of selection favoring <italic>KIR-A</italic> in East Asia is the low frequency of <italic>KIR-B</italic> haplotypes, specifically those that contain <italic>KIR2DL5B</italic> and <italic>KIR2DS3</italic>. In Amerindians, a complete loss of <italic>KIR2DS3</italic> is observed (<xref ref-type="bibr" rid="B50">50</xref>), and this may be tolerated because the common <italic>2DS3*00102</italic> allele does not form a functional receptor (<xref ref-type="bibr" rid="B81">81</xref>). In addition to gene content, <italic>KIR</italic> haplotypes characteristic to human populations are distinguished by the alleles they carry (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B82">82</xref>). Characteristic alleles of Zhejiang Han <italic>KIR-A</italic> haplotypes include <italic>KIR2DL1*003</italic>, <italic>KIR3DL1*015</italic>, and <italic>KIR3DL2*002</italic>, which all encode strongly inhibiting KIR allotypes, as defined by their ligand binding strength and signal transduction abilities. By contrast the <italic>KIR-B</italic> haplotypes carry fewer inhibitory receptors and they tend to be allotypes having weak affinity or signal transduction, including <italic>KIR2DL1*00401</italic> and <italic>KIR3DL2*00701</italic> (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B74">74</xref>). Thus, even in heterozygous individuals we may expect the functional signature of the <italic>KIR-A</italic> encoded receptors to dominate. The influence of <italic>KIR-B</italic> haplotypes being further diminished by the very low frequency of <italic>KIR-B</italic> homozygous genotypes in this population.</p>
<p>HLA-C evolved to be the dominant KIR ligand in humans (<xref ref-type="bibr" rid="B27">27</xref>). Chinese Han have a high frequency of <italic>HLA-B*46:01</italic>, which is only common in Asia and formed by recombination between <italic>HLA-B*15:01</italic> and <italic>HLA-C*01:02</italic> (<xref ref-type="bibr" rid="B83">83</xref>). <italic>HLA-B*46:01</italic> encodes an exceptional HLA-B allotype that can react with KIR2DL2/3, due to possession of a C1 ligand (<xref ref-type="bibr" rid="B26">26</xref>), and has risen to high frequency in this geographic region through admixture and natural selection (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B84">84</xref>). Candidates for this selection include endemic bacterial or viral infections (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B85">85</xref>&#x2013;<xref ref-type="bibr" rid="B89">89</xref>). An alternative explanation for selection acting on B*46 is that it provides a KIR ligand, whereas B*15:01, from which B*46:01 is derived, does not carry a KIR ligand (<xref ref-type="bibr" rid="B36">36</xref>). Co-evolution of KIR with HLA has been driven under natural selection, leading to frequency variation across populations for specific KIR&#x2013;HLA interactions (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B90">90</xref>). Our analysis identified many similarities in immunogenetic diversity between the Zhejiang Han and the closely related Shenzhen Han, from Southern China (<xref ref-type="bibr" rid="B36">36</xref>). Distinguishing the Zhejiang Han is a high frequency of <italic>KIR-A</italic> and <italic>C1<sup>+</sup>HLA-C</italic>, which is a genetic combination associated with preeclampsia (<xref ref-type="bibr" rid="B28">28</xref>). This serious multisystem disorder of pregnancy is most frequent in women homozygous both for <italic>KIR-A</italic> and <italic>C1<sup>+</sup>HLA-C</italic>, if the fetus carries C2<sup>+</sup>HLA-C (<xref ref-type="bibr" rid="B28">28</xref>). However, there is a substantially lower incidence of preeclampsia in China compared with western countries (<xref ref-type="bibr" rid="B91">91</xref>&#x2013;<xref ref-type="bibr" rid="B93">93</xref>), which is likely due to the lower frequency C2<sup>+</sup> ligands. Moreover, HLA-G expression by extravillous trophoblasts, which promotes vascular remodeling, may help ensure successful placentation thus preventing preeclampsia (<xref ref-type="bibr" rid="B94">94</xref>). HLA-G is a ligand for KIR2DL4 (<xref ref-type="bibr" rid="B67">67</xref>), and in Zhejiang Han the majority of <italic>KIR2DL4</italic> alleles express a functional allotype.</p>
<p>Uneven exchange during recombination events has been a frequent occurrence during <italic>KIR</italic> gene evolution, creating or amplifying structural diversity of the locus (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B95">95</xref>). Although our previous analysis of an independent cohort from Zhejiang Han identified similar frequencies of individual <italic>KIR</italic> genes (<xref ref-type="bibr" rid="B60">60</xref>), it was not previously possible to detect any additional structural diversity. In the present analysis of Zhejiang Han, which accounted for gene copy number in addition to gene presence, haplotypes carrying a <italic>KIR3DP1-2DL4-3DL1/S1</italic> insertion were observed in six individuals. Acquisition of full sequence data also permitted inference of the allele composition of these haplotypes. Similar haplotypes to those characterized here have been identified in European, Oceanian and other Asian populations, but are very rare in Africans (<xref ref-type="bibr" rid="B17">17</xref>). We identified a unique contracted haplotype lacking the telomeric segment, retaining only <italic>KIR2DL4</italic> as the 3&#x2019; terminal gene. The capture probes we used can tolerate up to 20% sequence divergence (<xref ref-type="bibr" rid="B33">33</xref>) and their high density in the target region would imply that we did not miss some highly divergent sequences from this individual. That the allele is <italic>KIR2DL4*00102</italic>, indicates that this contracted haplotype was formed from the most frequent <italic>KIR-A</italic> haplotype observed in the Zhejiang Han. As these recombination events most likely occur during meiosis, it remains unlikely that we will observe the reciprocal haplotype formed during that recombination event. That the more frequent structurally divergent haplotypes we observed are all characterized by recombination in approximately similar locations to each other, therefore suggests similar mechanisms or additional recombination hotspots abound in the <italic>KIR</italic> locus.</p>
<p>In conclusion, characterizing combinatorial diversity of <italic>KIR</italic> and <italic>HLA</italic> at high resolution in discrete populations is an important step toward understanding the roles of their polymorphism in disease and in human evolution. The mean number and diversity of KIR and HLA interactions in Zhejiang Han is similar to that of other East Asians, yet highly distinct from African, European and Oceanic populations. These findings will be important for analyzing diseases with susceptibilities that vary across populations and will form a baseline for individualizing immune-based therapies, including transplantation, in Southeastern China.</p>
</sec>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SF1"><bold>Supplementary Material</bold></xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by Blood Center of Zhejiang Province. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>ST and FZ designed experiments. ST and JW performed lab experiments. YH, KK, PN, and ST analyzed data. PN provided the technology and probes. ST, PN and FZ wrote the paper. All&#xa0;authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was sponsored by the Science Research Foundation of Zhejiang Province (LY18H080002) and Science Research Foundation of Zhejiang Healthy Bureau (2018RC003, 2019RC031). PN was supported by National Institutes of Health of the USA (R56 AI151549 and R01 AI128775).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank all the participants of this study for their generous donation of DNA to facilitate genetic research.</p>
</ack>
<sec id="s10" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2021.640334/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2021.640334/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table_1.xlsx" id="SF1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_2.xlsx" id="SF2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
<supplementary-material xlink:href="Table_3.xlsx" id="SF3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet">
<label>Supplementary Table 3</label>
<caption>
<p>Distribution of <bold>(A)</bold> centromeric and <bold>(B)</bold> telomeric <italic>KIR</italic> haplotypes in 176 Zhejiang Han individuals. KIR A haplotypes are shaded red and KIR B haplotypes shaded blue.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_4.xlsx" id="SF4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet">
<label>Supplementary Table 4</label>
<caption>
<p>Distribution of <bold>(A)</bold> <italic>HLA-A</italic>, <italic>-B</italic>, <italic>-C</italic> alleles and <bold>(B)</bold> <italic>HLA-A-B-C</italic> haplotypes in 176 Zhejiang Han individuals. KIR ligands are colored according to <xref ref-type="fig" rid="f6">
<bold>Figure 6A</bold>
</xref>, and those expressing -21M are indicated with orange shading.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_5.xlsx" id="SF5" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gyurova</surname> <given-names>IE</given-names>
</name>
<name>
<surname>Waggoner</surname> <given-names>SN</given-names>
</name>
</person-group>. <article-title>Mutually Assured Destruction: The Cold War Between Viruses and Natural Killer Cells</article-title>. <source>Curr Opin Virol</source> (<year>2019</year>) <volume>34</volume>:<page-range>130&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coviro.2019.02.005</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jost</surname> <given-names>S</given-names>
</name>
<name>
<surname>Altfeld</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Control of Human Viral Infections by Natural Killer Cells</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<page-range>163&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-100001</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname> <given-names>VC</given-names>
</name>
<name>
<surname>Lanier</surname> <given-names>LL</given-names>
</name>
</person-group>. <article-title>NK Cells in Host Responses to Viral Infections</article-title>. <source>Curr Opin Immunol</source> (<year>2017</year>) <volume>44</volume>:<fpage>43</fpage>&#x2013;<lpage>51</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coi.2016.11.003</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malmberg</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Carlsten</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bjorklund</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sohlberg</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bryceson</surname> <given-names>YT</given-names>
</name>
<name>
<surname>Ljunggren</surname> <given-names>HG</given-names>
</name>
</person-group>. <article-title>Natural Killer Cell-Mediated Immunosurveillance of Human Cancer</article-title>. <source>Semin Immunol</source> (<year>2017</year>) <volume>31</volume>:<page-range>20&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.smim.2017.08.002</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crespo &#xc2;</surname> <given-names>C</given-names>
</name>
<name>
<surname>van der Zwan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ramalho-Santos</surname> <given-names>J</given-names>
</name>
<name>
<surname>Strominger</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Tilburgs</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Cytotoxic Potential of Decidual NK Cells and CD8+ T Cells Awakened by Infections</article-title>. <source>J Reprod Immunol</source> (<year>2017</year>) <volume>119</volume>:<fpage>85</fpage>&#x2013;<lpage>90</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jri.2016.08.001</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname> <given-names>EO</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Rajagopalan</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<page-range>227&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075005</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trowsdale</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Genetic and Functional Relationships Between MHC and NK Receptor Genes</article-title>. <source>Immunity</source> (<year>2001</year>) <volume>15</volume>:<page-range>363&#x2013;74</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1074-7613(01)00197-2</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
<name>
<surname>Moffett</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Variable NK Cell Receptors and Their MHC Class I Ligands in Immunity, Reproduction and Human Evolution</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>(<issue>2</issue>):<page-range>133&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3370</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moretta</surname> <given-names>L</given-names>
</name>
<name>
<surname>Moretta</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Unravelling Natural Killer Cell Function: Triggering and Inhibitory Human NK Receptors</article-title>. <source>EMBO J</source> (<year>2004</year>) <volume>233</volume>:<page-range>255&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.emboj.7600019</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bashirova</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>MP</given-names>
</name>
<name>
<surname>McVicar</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Carrington</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The Killer Immunoglobulin-Like Receptor Gene Cluster: Tuning the Genome for Defense</article-title>. <source>Annu Rev Genomics Hum Genet</source> (<year>2006</year>) <volume>7</volume>:<fpage>277</fpage>&#x2013;<lpage>300</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.genom.7.080505.115726</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beziat</surname> <given-names>V</given-names>
</name>
<name>
<surname>Hilton</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Traherne</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Deciphering the Killer-Cell Immunoglobulin-Like Receptor System At Super-Resolution for Natural Killer and T-cell Biology</article-title>. <source>Immunology</source> (<year>2017</year>) <volume>150</volume>(<issue>3</issue>):<page-range>248&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.12684</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anfossi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Andre</surname> <given-names>P</given-names>
</name>
<name>
<surname>Guia</surname> <given-names>S</given-names>
</name>
<name>
<surname>Falk</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Roetynck</surname> <given-names>S</given-names>
</name>
<name>
<surname>Stewart</surname> <given-names>CA</given-names>
</name>
<etal/>
</person-group>. <article-title>Human NK Cell Education by Inhibitory Receptors for MHC Class I</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>25</volume>(<issue>2</issue>):<page-range>331&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2006.06.013</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boudreau</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>KC</given-names>
</name>
</person-group>. <article-title>Natural Killer Cell Education in Human Health and Disease</article-title>. <source>Curr Opin Immunol</source> (<year>2018</year>) <volume>50</volume>:<page-range>102&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.coi.2017.11.003</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodridge</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Jacobs</surname> <given-names>B</given-names>
</name>
<name>
<surname>Saetersmoen</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Clement</surname> <given-names>D</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Clancy</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Remodeling of Secretory Lysosomes During Education Tunes Functional Potential in NK Cells</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>(<issue>1</issue>):<fpage>514</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-08384-x</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Torkar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Haude</surname> <given-names>A</given-names>
</name>
<name>
<surname>Milne</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sheer</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Plasticity in the Organization and Sequences of Human KIR/ILT Gene Families</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2000</year>) <volume>97</volume>(<issue>9</issue>):<page-range>4778&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.080588597</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pyo</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Vu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-like Receptor Locus</article-title>. <source>PloS One</source> (<year>2010</year>) <volume>5</volume>:<fpage>e15115</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0015115.g001</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gendzekhadze</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hammond</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Moesta</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Meiotic Recombination Generates Rich Diversity in NK Cell Receptor Genes, Alleles, and Haplotypes</article-title>. <source>Genome Res</source> (<year>2009</year>) <volume>19</volume>(<issue>5</issue>):<page-range>757&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gr.085738.108</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Traherne</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ward</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ohashi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pellett</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gladman</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Mechanisms of Copy Number Variation and Hybrid Gene Formation in the KIR Immune Gene Complex</article-title>. <source>Hum Mol Genet</source> (<year>2010</year>) <volume>19</volume>(<issue>5</issue>):<page-range>737&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hmg/ddp538</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Vivian</surname> <given-names>JP</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Sullivan</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Pymm</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rossjohn</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>A Bird&#x2019;s Eye View of NK Cell Receptor Interactions With Their MHC Class I Ligands</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>267</volume>(<issue>1</issue>):<page-range>148&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12319</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilton</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Goyos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nemat-Gorgani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bushnell</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>(<issue>7</issue>):<page-range>3160&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1501358</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gumperz</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Barber</surname> <given-names>LD</given-names>
</name>
<name>
<surname>Valiante</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Percival</surname> <given-names>L</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Lanier</surname> <given-names>LL</given-names>
</name>
<etal/>
</person-group>. <article-title>Conserved and Variable Residues Within the Bw4 Motif of HLA-B Make Separable Contributions to Recognition by the NKB1 Killer Cell-Inhibitory Receptor</article-title>. <source>J Immunol</source> (<year>1997</year>) <volume>158</volume>(<issue>11</issue>):<page-range>5237&#x2013;41</page-range>.</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname> <given-names>PM</given-names>
</name>
<name>
<surname>MacLachlan</surname> <given-names>BJ</given-names>
</name>
<name>
<surname>Widjaja</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Oates</surname> <given-names>CVL</given-names>
</name>
<name>
<surname>Rossjohn</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>The Role of the HLA Class I &#x3b1;2 Helix in Determining Ligand Hierarchy for the Killer Cell Ig-like Receptor 3dl1</article-title>. <source>J Immunol</source> (<year>2021</year>) <volume>206</volume>(<issue>4</issue>):<page-range>849&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.2001109</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manser</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Weinhold</surname> <given-names>S</given-names>
</name>
<name>
<surname>Uhrberg</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Human KIR Repertoires Shaped by Genetic Diversity and Evolution</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>267</volume>:<page-range>178&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12316</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graef</surname> <given-names>T</given-names>
</name>
<name>
<surname>Moesta</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<name>
<surname>Vago</surname> <given-names>L</given-names>
</name>
<name>
<surname>Older Aguilar</surname> <given-names>AM</given-names>
</name>
<etal/>
</person-group>. <article-title>KIR2DS4 is a Product of Gene Conversion With KIR3DL2 That Introduced Specificity for HLA-A*11 While Diminishing Avidity for HLA-C</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>(<issue>11</issue>):<page-range>2557&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20091010</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Middleton</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gonzelez</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>The Extensive Polymorphism of KIR Genes</article-title>. <source>Immunology</source> (<year>2010</year>) <volume>129</volume>(<issue>1</issue>):<fpage>8</fpage>&#x2013;<lpage>19</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2567.2009.03208.x</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moesta</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Yawata</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yawata</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gleimer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Synergistic Polymorphism At Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3</article-title>. <source>J&#xa0;Immunol</source> (<year>2008</year>) <volume>180</volume>(<issue>6</issue>):<page-range>3969&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.180.6.3969</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>Human-Specific Evolution of Killer Cell Immunoglobulin-Like Receptor Recognition of Major Histocompatibility Complex Class I Molecules</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source> (<year>2012</year>) <volume>367</volume>(<issue>1590</issue>):<page-range>800&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rstb.2011.0266</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiby</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>O&#x2019;Shaughnessy K</surname> <given-names>M</given-names>
</name>
<name>
<surname>Redman</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Carrington</surname> <given-names>M</given-names>
</name>
<name>
<surname>Trowsdale</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success</article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>200</volume>(<issue>8</issue>):<page-range>957&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20041214</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khakoo</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Thio</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Brooks</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Astemborski</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection</article-title>. <source>Science</source> (<year>2004</year>) <volume>305</volume>(<issue>5685</issue>):<page-range>872&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1097670</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakimuli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chazara</surname> <given-names>O</given-names>
</name>
<name>
<surname>Hiby</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Farrell</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tukwasibwe</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jayaraman</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>A Kir B Centromeric Region Present in Africans But Not Europeans Protects Pregnant Women From Pre-Eclampsia</article-title>. <source>Proc Natl Acad Sci</source> (<year>2015</year>) <volume>112</volume>(<issue>3</issue>):<page-range>845&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1413453112</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooley</surname> <given-names>S</given-names>
</name>
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
<name>
<surname>Miller</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Strategies to Activate NK Cells to Prevent Relapse and Induce Remission Following Hematopoietic Stem Cell Transplantation</article-title>. <source>Blood</source> (<year>2018</year>) <volume>131</volume>(<issue>10</issue>):<page-range>1053&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2017-08-752170</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname> <given-names>J</given-names>
</name>
<name>
<surname>Halliwell</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Hayhurst</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Flicek</surname> <given-names>P</given-names>
</name>
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
<name>
<surname>Marsh</surname> <given-names>SG</given-names>
</name>
</person-group>. <article-title>The IPD and IMGT/HLA Database: Allele Variant Databases</article-title>. <source>Nucleic Acids Res</source> (<year>2015</year>) <volume>43</volume>(<issue>Database issue</issue>):<page-range>D423&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gku1161</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Hollenbach</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Nemat-Gorgani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Marin</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Norberg</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Ashouri</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Defining KIR and HLA Class I Genotypes At Highest Resolution Via High-Throughput Sequencing</article-title>. <source>Am J Hum Genet</source> (<year>2016</year>) <volume>99</volume>(<issue>2</issue>):<page-range>375&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.06.023</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nemat-Gorgani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hilton</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Henn</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gignoux</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Myrick</surname> <given-names>JW</given-names>
</name>
<etal/>
</person-group>. <article-title>Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 With C2(+) HLA-C in Two Indigenous Human Populations in Southern Africa</article-title>. <source>J Immunol</source> (<year>2018</year>) <volume>200</volume>(<issue>8</issue>):<page-range>2640&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1701780</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname> <given-names>I</given-names>
</name>
<name>
<surname>Schefzyk</surname> <given-names>D</given-names>
</name>
<name>
<surname>Pruschke</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sch&#xf6;fl</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sch&#xf6;ne</surname> <given-names>B</given-names>
</name>
<name>
<surname>Gruber</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>2843</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02843</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Harrison</surname> <given-names>GF</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians</article-title>. <source>Mol Biol Evol</source> (<year>2021</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1093/molbev/msab053</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yawata</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yawata</surname> <given-names>N</given-names>
</name>
<name>
<surname>Draghi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Little</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Partheniou</surname> <given-names>F</given-names>
</name>
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Roles for HLA and KIR Polymorphisms in Natural Killer Cell Repertoire Selection and Modulation of Effector Function</article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>203</volume>(<issue>3</issue>):<page-range>633&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20051884</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephens</surname> <given-names>M</given-names>
</name>
<name>
<surname>Donnelly</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>A Comparison of Bayesian Methods for Haplotype Reconstruction From_ Population Genotype Data</article-title>. <source>Am J Hum Genet</source> (<year>2003</year>) <volume>73</volume>:<page-range>1162&#x2013;16</page-range>. doi: <pub-id pub-id-type="doi">10.1086/379378</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Galarza</surname> <given-names>FF</given-names>
</name>
<name>
<surname>McCabe</surname> <given-names>A</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>E</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>J</given-names>
</name>
<name>
<surname>Takeshita</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ortega-Rivera</surname> <given-names>ND</given-names>
</name>
<etal/>
</person-group>. <article-title>Allele Frequency Net Database (AFND) 2020 Update: Gold-Standard Data Classification, Open Access Genotype Data and New Query Tools</article-title>. <source>Nucleic Acids Res</source> (<year>2020</year>) <volume>48</volume>(<issue>D1</issue>):<page-range>D783&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkz1029</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Excoffier</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lischer</surname> <given-names>HE</given-names>
</name>
</person-group>. <article-title>Arlequin Suite Ver 3.5: A New Series of Programs to Perform Population Genetics Analyses Under Linux and Windows</article-title>. <source>Mol Ecol Resour</source> (<year>2010</year>) <volume>10</volume>(<issue>3</issue>):<page-range>564&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1755-0998.2010.02847.x</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augusto</surname> <given-names>DG</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Lobo-Alves</surname> <given-names>SC</given-names>
</name>
<name>
<surname>Bass</surname> <given-names>S</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Carrington</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Pemphigus is Associated With KIR3DL2 Expression Levels and Provides Evidence That KIR3DL2 may Bind HLA-A3 and A11 In Vivo</article-title>. <source>Eur J Immunol</source> (<year>2015</year>) <volume>45</volume>(<issue>7</issue>):<page-range>2052&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.201445324</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansasuta</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>T</given-names>
</name>
<name>
<surname>Thananchai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Weekes</surname> <given-names>M</given-names>
</name>
<name>
<surname>Willberg</surname> <given-names>C</given-names>
</name>
<name>
<surname>Aldemir</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is Peptide-Specific</article-title>. <source>Eur J Immunol</source> (<year>2004</year>) <volume>34</volume>(<issue>6</issue>):<page-range>1673&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.200425089</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whang</surname> <given-names>DH</given-names>
</name>
<name>
<surname>Park</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Park</surname> <given-names>MH</given-names>
</name>
</person-group>. <article-title>Haplotype Analysis of Killer Cell Immunoglobulin-Like Receptor Genes in 77 Korean Families</article-title>. <source>Hum Immunol</source> (<year>2005</year>) <volume>66</volume>(<issue>2</issue>):<page-range>146&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.humimm.2004.10.013</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>GQ</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>XY</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Distribution of Killer-Cell Immunoglobulin-Like Receptor Genes in Eastern Mainland Chinese Han and Taiwanese Han Populations</article-title>. <source>Tissue Antigens</source> (<year>2009</year>) <volume>74</volume>(<issue>6</issue>):<fpage>499</fpage>&#x2013;<lpage>507</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0039.2009.01366.x</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kichula</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Harrison</surname> <given-names>GF</given-names>
</name>
<name>
<surname>Farias</surname> <given-names>TDJ</given-names>
</name>
<name>
<surname>Palmer</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Leaton</surname> <given-names>LA</given-names>
</name>
<etal/>
</person-group>. <article-title>The Combinatorial Diversity of KIR and HLA Class I Allotypes in Peninsular Malaysia</article-title>. <source>Immunology</source> (<year>2021</year>) <volume>162</volume>(<issue>4</issue>):<fpage>389</fpage>&#x2013;<lpage>404</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.13289</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaisri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kitcharoen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Romphruk</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Romphruk</surname> <given-names>A</given-names>
</name>
<name>
<surname>Witt</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Leelayuwat</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Polymorphisms of Killer Immunoglobulin-Like Receptors (Kirs) and HLA Ligands in Northeastern Thais</article-title>. <source>Immunogenetics</source> (<year>2013</year>) <volume>65</volume>(<issue>9</issue>):<page-range>645&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00251-013-0716-7</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hidajat</surname> <given-names>M</given-names>
</name>
<name>
<surname>Selleslag</surname> <given-names>D</given-names>
</name>
<name>
<surname>Van Hoof</surname> <given-names>A</given-names>
</name>
<name>
<surname>Van Droogenbroeck</surname> <given-names>J</given-names>
</name>
<name>
<surname>Billiet</surname> <given-names>J</given-names>
</name>
<name>
<surname>Criel</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Killer Immunoglobulin-Like Receptors (Kirs) Genotypes in a Belgian Population</article-title>. <source>Blood</source> (<year>2004</year>) <volume>104</volume>(<issue>11</issue>):<fpage>3852</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood.V104.11.3852.3852</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnheim</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dillner</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sanjeevi</surname> <given-names>CB</given-names>
</name>
</person-group>. <article-title>A Population-Based Cohort Study of KIR Genes and Genotypes in Relation to Cervical Intraepithelial Neoplasia</article-title>. <source>Tissue Antigens</source> (<year>2005</year>) <volume>65</volume>(<issue>3</issue>):<page-range>252&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0039.2005.00359.x</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Hollenbach</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Nemat-Gorgani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Hilton</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Pando</surname> <given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Co-Evolution of Human Leukocyte Antigen (HLA) Class I Ligands With Killer-Cell Immunoglobulin-Like Receptors (KIR) in a Genetically Diverse Population of sub-Saharan Africans</article-title>. <source>PloS Genet</source> (<year>2013</year>) <volume>9</volume>(<issue>10</issue>):<elocation-id>e1003938</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1003938</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gendzekhadze</surname> <given-names>K</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<name>
<surname>Graef</surname> <given-names>T</given-names>
</name>
<name>
<surname>Moesta</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Layrisse</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Co-Evolution of KIR2DL3 With HLA-C in a Human Population Retaining Minimal Essential Diversity of KIR and HLA Class I Ligands</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2009</year>) <volume>106</volume>(<issue>44</issue>):<page-range>18692&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0906051106</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uhrberg</surname> <given-names>M</given-names>
</name>
<name>
<surname>Valiante</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Shum</surname> <given-names>BP</given-names>
</name>
<name>
<surname>Shilling</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Lienert-Weidenbach</surname> <given-names>K</given-names>
</name>
<name>
<surname>Corliss</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Human Diversity in Killer Cell Inhibitory Receptor Genes</article-title>. <source>Immunity</source> (<year>1997</year>) <volume>9</volume>:<page-range>753&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1074-7613(00)80394-5</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>HD</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>QJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Killer Cell Immunoglobulin-Like Receptor Gene Diversity in the Tibetan Ethnic Minority Group of China</article-title>. <source>Hum Immunol</source> (<year>2010</year>) <volume>71</volume>(<issue>11</issue>):<page-range>1116&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.humimm.2010.07.010</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>EC</given-names>
</name>
</person-group>. <article-title>Asian Population Frequencies and Haplotype Distribution of Killer Cell Immunoglobulin-Like Receptor (KIR) Genes Among Chinese, Malay, and Indian in Singapore</article-title>. <source>Immunogenetics</source> (<year>2008</year>) <volume>60</volume>(<issue>11</issue>):<page-range>645&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00251-008-0321-3</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augusto</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Amorim</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Farias</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Petzl-Erler</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>KIR and HLA Genotyping of Japanese Descendants From Curitiba, a City of Predominantly European Ancestry From Southern Brazil</article-title>. <source>Hum Immunol</source> (<year>2016</year>) <volume>77</volume>(<issue>4</issue>):<page-range>336&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.humimm.2016.01.011</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiby</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Ashrafian-Bonab</surname> <given-names>M</given-names>
</name>
<name>
<surname>Farrell</surname> <given-names>L</given-names>
</name>
<name>
<surname>Single</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Balloux</surname> <given-names>F</given-names>
</name>
<name>
<surname>Carrington</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Distribution of Killer Cell Immunoglobulin-Like Receptors (KIR) and Their HLA-C Ligands in Two Iranian Populations</article-title>. <source>Immunogenetics</source> (<year>2010</year>) <volume>62</volume>(<issue>2</issue>):<fpage>65</fpage>&#x2013;<lpage>73</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00251-009-0408-5</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seymour</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Nourse</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Crooks</surname> <given-names>P</given-names>
</name>
<name>
<surname>Wockner</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bird</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tran</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The Presence of KIR2DS5 Confers Protection Against Adult Immune Thrombocytopenia</article-title>. <source>Tissue Antigens</source> (<year>2014</year>) <volume>83</volume>(<issue>3</issue>):<page-range>154&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/tan.12295</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakimuli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chazara</surname> <given-names>O</given-names>
</name>
<name>
<surname>Farrell</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hiby</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Tukwasibwe</surname> <given-names>S</given-names>
</name>
<name>
<surname>Knee</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Killer Cell Immunoglobulin-Like Receptor (KIR) Genes and Their HLA-C Ligands in a Ugandan Population</article-title>. <source>Immunogenetics</source> (<year>2013</year>) <volume>65</volume>(<issue>11</issue>):<page-range>765&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00251-013-0724-7</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velickovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Velickovic</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Dunckley</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Diversity of Killer Cell Immunoglobulin-Like Receptor Genes in Pacific Islands Populations</article-title>. <source>Immunogenetics</source> (<year>2006</year>) <volume>58</volume>(<issue>7</issue>):<page-range>523&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00251-006-0124-3</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velickovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Velickovic</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Panigoro</surname> <given-names>R</given-names>
</name>
<name>
<surname>Dunckley</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Diversity of Killer Cell Immunoglobulin-Like Receptor Genes in Indonesian Populations of Java, Kalimantan, Timor and Irian Jaya</article-title>. <source>Tissue Antigens</source> (<year>2009</year>) <volume>73</volume>(<issue>1</issue>):<fpage>9</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0039.2008.01149.x</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>QF</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>LX</given-names>
</name>
</person-group>. <article-title>Distribution of Killer Cell Immunoglobulin-Like Receptor Genes in the Chinese Han Population</article-title>. <source>Tissue Antigens</source> (<year>2005</year>) <volume>65</volume>(<issue>6</issue>):<page-range>556&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1399-0039.2005.00412.x</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruijnesteijn</surname> <given-names>J</given-names>
</name>
<name>
<surname>de Groot</surname> <given-names>NG</given-names>
</name>
<name>
<surname>Bontrop</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>The Genetic Mechanisms Driving Diversification of the KIR Gene Cluster in Primates</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>582804</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.582804</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nemat-Gorgani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Edinur</surname> <given-names>HA</given-names>
</name>
<name>
<surname>Hollenbach</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Traherne</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Dunn</surname> <given-names>PP</given-names>
</name>
<name>
<surname>Chambers</surname> <given-names>GK</given-names>
</name>
<etal/>
</person-group>. <article-title>KIR Diversity in Maori and Polynesians: Populations in Which HLA-B is Not a Significant KIR Ligand</article-title>. <source>Immunogenetics</source> (<year>2014</year>) <volume>66</volume>(<issue>11</issue>):<fpage>597</fpage>&#x2013;<lpage>611</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00251-014-0794-1</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boudreau</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Mulrooney</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Le Luduec</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Barker</surname> <given-names>E</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>KC</given-names>
</name>
</person-group>. <article-title>KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV</article-title>. <source>J&#xa0;Immunol</source> (<year>2016</year>) <volume>196</volume>(<issue>8</issue>):<page-range>3398&#x2013;410</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1502469</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Pymm</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pietra</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hughes</surname> <given-names>VA</given-names>
</name>
<name>
<surname>Hitchen</surname> <given-names>C</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname> <given-names>GM</given-names>
</name>
<etal/>
</person-group>. <article-title>Killer Cell Immunoglobulin-Like Receptor 3DL1 Polymorphism Defines Distinct Hierarchies of HLA Class I Recognition</article-title>. <source>J Exp Med</source> (<year>2016</year>) <volume>213</volume>(<issue>5</issue>):<fpage>791</fpage>&#x2013;<lpage>807</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20152023</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amorim</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Augusto</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Nemat-Gorgani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Montero-Martin</surname> <given-names>G</given-names>
</name>
<name>
<surname>Marin</surname> <given-names>W</given-names>
</name>
<name>
<surname>Shams</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>High-Resolution Characterization of KIR Genes in a Large North American Cohort Reveals Novel Details of Structural and Sequence Diversity</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>674778</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.674778</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname> <given-names>SD</given-names>
</name>
<name>
<surname>He</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Ying</surname> <given-names>YL</given-names>
</name>
<name>
<surname>He</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>HJ</given-names>
</name>
</person-group>. <article-title>KIR3DL1 Genetic Diversity and Phenotypic Variation in the Chinese Han Population</article-title>. <source>Genes Immun</source> (<year>2014</year>) <volume>15</volume>(<issue>1</issue>):<fpage>8</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/gene.2013.55</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajagopalan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Long</surname> <given-names>EO</given-names>
</name>
</person-group>. <article-title>A Human Histocompatibility Leukocyte Antigen (HLA)-G-specific Receptor Expressed on All Natural Killer Cells</article-title>. <source>J Exp Med</source> (<year>1999</year>) <volume>189</volume>(<issue>7</issue>):<page-range>1093&#x2013;100</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.189.7.1093</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kikuchi-Maki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Catina</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>KS</given-names>
</name>
</person-group>. <article-title>Cutting Edge: KIR2DL4 Transduces Signals Into Human NK Cells Through Association With the Fc Receptor Gamma Protein</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>(<issue>7</issue>):<page-range>3859&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.174.7.3859</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witt</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>A</given-names>
</name>
<name>
<surname>Christiansen</surname> <given-names>FT</given-names>
</name>
</person-group>. <article-title>Detection of KIR2DL4 Alleles by Sequencing and SSCP Reveals a Common Allele With a Shortened Cytoplasmic Tail</article-title>. <source>Tissue Antigens</source> (<year>2000</year>) <volume>56</volume>(<issue>3</issue>):<page-range>248&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1034/j.1399-0039.2000.560307.x</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Bashirova</surname> <given-names>A</given-names>
</name>
<name>
<surname>Traherne</surname> <given-names>J</given-names>
</name>
<name>
<surname>Trowsdale</surname> <given-names>J</given-names>
</name>
<name>
<surname>Carrington</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>171</volume>(<issue>5</issue>):<page-range>2192&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.171.5.2192</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xf3;mez-Lozano</surname> <given-names>N</given-names>
</name>
<name>
<surname>Estefan&#xed;a</surname> <given-names>E</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>F</given-names>
</name>
<name>
<surname>Halfpenny</surname> <given-names>I</given-names>
</name>
<name>
<surname>Middleton</surname> <given-names>D</given-names>
</name>
<name>
<surname>Sol&#xed;s</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>The Silent KIR3DP1 Gene (CD158c) is Transcribed and Might Encode a Secreted Receptor in a Minority of Humans, in Whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 Genes are Duplicated</article-title>. <source>Eur J Immunol</source> (<year>2005</year>) <volume>35</volume>(<issue>1</issue>):<fpage>16</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/eji.200425493</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cisneros</surname> <given-names>E</given-names>
</name>
<name>
<surname>Moraru</surname> <given-names>M</given-names>
</name>
<name>
<surname>G&#xf3;mez-Lozano</surname> <given-names>N</given-names>
</name>
<name>
<surname>Muntasell</surname> <given-names>A</given-names>
</name>
<name>
<surname>L&#xf3;pez-Botet</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vilches</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Haplotype-Based Analysis of KIR-Gene Profiles in a South European Population-Distribution of Standard and Variant Haplotypes, and Identification of Novel Recombinant Structures</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>440</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.00440</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilton</surname> <given-names>HG</given-names>
</name>
<name>
<surname>Vago</surname> <given-names>L</given-names>
</name>
<name>
<surname>Older Aguilar</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Moesta</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Graef</surname> <given-names>T</given-names>
</name>
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutation At Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 is a More Refined But Less Adaptable NK Cell Receptor Than KIR2DL3</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>(<issue>3</issue>):<page-range>1418&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1100431</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bari</surname> <given-names>R</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>T</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Vong</surname> <given-names>QP</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Das Gupta</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Significant Functional Heterogeneity Among KIR2DL1 Alleles and a Pivotal Role of Arginine 245</article-title>. <source>Blood</source> (<year>2009</year>) <volume>114</volume>(<issue>25</issue>):<page-range>5182&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2009-07-231977</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braud</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Allan</surname> <given-names>DS</given-names>
</name>
<name>
<surname>O&#x2019;Callaghan</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Soderstrom</surname> <given-names>K</given-names>
</name>
<name>
<surname>D&#x2019;Andrea</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ogg</surname> <given-names>GS</given-names>
</name>
<etal/>
</person-group>. <article-title>HLA-E Binds to Natural Killer Cell Receptors CD94/NKG2A, B, and C</article-title>. <source>Nature</source> (<year>1998</year>) <volume>391</volume>(<issue>6669</issue>):<page-range>795&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/35869</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname> <given-names>BI</given-names>
</name>
<name>
<surname>Devine</surname> <given-names>OP</given-names>
</name>
<name>
<surname>Vukmanovic-Stejic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chambers</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Subramanian</surname> <given-names>P</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Senescent Cells Evade Immune Clearance Via HLA-E-mediated NK and CD8(+) T Cell Inhibition</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>(<issue>1</issue>):<fpage>2387</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-019-10335-5</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sunwoo</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Song</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>French</surname> <given-names>AR</given-names>
</name>
<etal/>
</person-group>. <article-title>HLA Alleles Determine Differences in Human Natural Killer Cell Responsiveness and Potency</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2008</year>) <volume>105</volume>(<issue>8</issue>):<page-range>3053&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.0712229105</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augusto</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Norman</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Dandekar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Hollenbach</surname> <given-names>JA</given-names>
</name>
</person-group>. <article-title>Fluctuating and Geographically Specific Selection Characterize Rapid Evolution of the Human Kir Region</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>989</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00989</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>S</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>MP</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1646</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01646</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollenbach</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Augusto</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Alaez</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bubnova</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fae</surname> <given-names>I</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>16(Th) IHIW: Population Global Distribution of Killer Immunoglobulin-Like Receptor (KIR) and Ligands</article-title>. <source>Int J Immunogenet</source> (<year>2013</year>) <volume>40</volume>(<issue>1</issue>):<fpage>39</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/iji.12028</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>VandenBussche</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Mulrooney</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Frazier</surname> <given-names>WR</given-names>
</name>
<name>
<surname>Dakshanamurthy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hurley</surname> <given-names>CK</given-names>
</name>
</person-group>. <article-title>Dramatically Reduced Surface Expression of NK Cell Receptor KIR2DS3 is Attributed to Multiple Residues Throughout the Molecule</article-title>. <source>Genes Immun</source> (<year>2009</year>) <volume>10</volume>(<issue>2</issue>):<page-range>162&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/gene.2008.91</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alicata</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ashouri</surname> <given-names>E</given-names>
</name>
<name>
<surname>Nemat-Gorgani</surname> <given-names>N</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Marin</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Kir Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>556</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.00556</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname> <given-names>LD</given-names>
</name>
<name>
<surname>Percival</surname> <given-names>L</given-names>
</name>
<name>
<surname>Valiante</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gumperz</surname> <given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>The Inter-Locus Recombinant HLA-B*4601 has High Selectivity in Peptide Binding and Functions Characteristic of HLA-C</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>184</volume>(<issue>2</issue>):<page-range>735&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.184.2.735</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abi-Rached</surname> <given-names>L</given-names>
</name>
<name>
<surname>Moesta</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Rajalingam</surname> <given-names>R</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Parham</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Human-Specific Evolution and Adaptation Led to Major Qualitative Differences in the Variable Receptors of Human and Chimpanzee Natural Killer Cells</article-title>. <source>PloS Genet</source> (<year>2010</year>) <volume>6</volume>(<issue>11</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1001192</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thons</surname> <given-names>C</given-names>
</name>
<name>
<surname>Senff</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hydes</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Manser</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Heinemann</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Heinold</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Hla-Bw4 80(T) and Multiple HLA-Bw4 Copies Combined With KIR3DL1 Associate With Spontaneous Clearance of HCV Infection in People Who Inject Drugs</article-title>. <source>J Hepatol</source> (<year>2017</year>) <volume>67</volume>(<issue>3</issue>):<page-range>462&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhep.2017.03.040</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petitdemange</surname> <given-names>C</given-names>
</name>
<name>
<surname>Becquart</surname> <given-names>P</given-names>
</name>
<name>
<surname>Wauquier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Beziat</surname> <given-names>V</given-names>
</name>
<name>
<surname>Debre</surname> <given-names>P</given-names>
</name>
<name>
<surname>Leroy</surname> <given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Unconventional Repertoire Profile is Imprinted During Acute Chikungunya Infection for Natural Killer Cells Polarization Toward Cytotoxicity</article-title>. <source>PloS Pathog</source> (<year>2011</year>) <volume>7</volume>(<issue>9</issue>):<elocation-id>e1002268</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1002268</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Townsley</surname> <given-names>E</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cosgrove</surname> <given-names>C</given-names>
</name>
<name>
<surname>Woda</surname> <given-names>M</given-names>
</name>
<name>
<surname>Co</surname> <given-names>M</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Interaction of a Dengue Virus NS1-derived Peptide With the Inhibitory Receptor KIR3DL1 on Natural Killer Cells</article-title>. <source>Clin Exp Immunol</source> (<year>2016</year>) <volume>183</volume>(<issue>3</issue>):<page-range>419&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cei.12722</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naiyer</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Cassidy</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Magri</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cowton</surname> <given-names>V</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mansour</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>KIR2DS2 Recognizes Conserved Peptides Derived From Viral Helicases in the Context of HLA-C</article-title>. <source>Sci Immunol</source> (<year>2017</year>) <volume>2</volume>(<issue>15</issue>):<page-range>eaal5296</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciimmunol.aal5296</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hilton</surname> <given-names>HG</given-names>
</name>
<name>
<surname>McMurtrey</surname> <given-names>CP</given-names>
</name>
<name>
<surname>Han</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Djaoud</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Guethlein</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Blokhuis</surname> <given-names>JH</given-names>
</name>
<etal/>
</person-group>. <article-title>The Intergenic Recombinant HLA-B&#x2217;46:01 has a Distinctive Peptidome That Includes Kir2dl3 Ligands</article-title>. <source>Cell Rep</source> (<year>2017</year>) <volume>19</volume>(<issue>7</issue>):<page-range>1394&#x2013;405</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.059</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Single</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yeager</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kidd</surname> <given-names>JR</given-names>
</name>
<etal/>
</person-group>. <article-title>Global Diversity and Evidence for Coevolution of KIR and HLA</article-title>. <source>Nat Genet</source> (<year>2007</year>) <volume>39</volume>(<issue>9</issue>):<page-range>1114&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ng2077</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Knibbs</surname> <given-names>LD</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of Prenatal Exposure to Air Pollution on Preeclampsia in Shenzhen, China</article-title>. <source>Environ Pollution</source> (<year>2018</year>) <volume>237</volume>:<fpage>18</fpage>&#x2013;<lpage>27</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.envpol.2018.02.010</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Algert</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Antonsen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chalmers</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cnattingius</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Population-Based Trends in Pregnancy Hypertension and Pre-Eclampsia: An International Comparative Study</article-title>. <source>BMJ Open</source> (<year>2011</year>) <volume>1</volume>(<issue>1</issue>):<elocation-id>e000101</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmjopen-2011-000101</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ananth</surname> <given-names>CV</given-names>
</name>
<name>
<surname>Keyes</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Wapner</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Pre-Eclampsia Rates in the United States, 1980-2010: Age-Period-Cohort Analysis</article-title>. <source>Bmj</source> (<year>2013</year>) <volume>347</volume>(<issue>nov07 15</issue>):<elocation-id>f6564</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.f6564</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pazmany</surname> <given-names>L</given-names>
</name>
<name>
<surname>Mandelboim</surname> <given-names>O</given-names>
</name>
<name>
<surname>Vales-Gomez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Reyburn</surname> <given-names>HT</given-names>
</name>
<etal/>
</person-group>. <article-title>Human Leucocyte Antigen-G and its Recognition by Natural Killer Cells</article-title>. <source>J Reprod Immunol</source> (<year>1999</year>) <volume>43</volume>(<issue>2</issue>):<page-range>127&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0165-0378(99)00028-5</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jayaraman</surname> <given-names>J</given-names>
</name>
<name>
<surname>Simecek</surname> <given-names>N</given-names>
</name>
<name>
<surname>Noble</surname> <given-names>J</given-names>
</name>
<name>
<surname>Moffatt</surname> <given-names>MF</given-names>
</name>
<etal/>
</person-group>. <article-title>Copy Number Variation Leads to Considerable Diversity for B But Not A Haplotypes of the Human KIR Genes Encoding NK Cell Receptors</article-title>. <source>Genome Res</source> (<year>2012</year>) <volume>22</volume>(<issue>10</issue>):<page-range>1845&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gr.137976.112</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>